Literature DB >> 31770591

Mitochondrial dysfunction in neurons in Friedreich's ataxia.

Anna Stepanova1, Jordi Magrané2.   

Abstract

Friedreich's ataxia is a multisystemic genetic disorder within the family of mitochondrial diseases that is characterized by reduced levels of the essential mitochondrial protein frataxin. Based on clinical evidence, the peripheral nervous system is affected early, neuronal dysfunction progresses towards the central nervous system, and other organs (such as heart and pancreas) are affected later. However, little attention has been given to the specific aspects of mitochondria function altered by frataxin depletion in the nervous system. For years, commonly accepted views on mitochondria dysfunction in Friedreich's ataxia stemmed from studies using non-neuronal systems and may not apply to neurons, which have their own bioenergetic needs and present a unique, extensive neurite network. Moreover, the basis of the selective neuronal vulnerability, which primarily affects large sensory neurons in the dorsal root ganglia, large principal neurons in the dentate nuclei of the cerebellum, and pyramidal neurons in the cerebral cortex, remains elusive. In order to identify potential misbeliefs in the field and highlight controversies, we reviewed current knowledge on frataxin expression in different tissues, discussed the molecular function of frataxin, and the consequences of its deficiency for mitochondria structural and functional properties, with a focus on the nervous system.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axonal transport; Calcium; Frataxin; Mitochondrial respiratory chain; Morphology; Peripheral nervous system; Sensory neurons

Mesh:

Substances:

Year:  2019        PMID: 31770591     DOI: 10.1016/j.mcn.2019.103419

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  8 in total

Review 1.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

Review 2.  Iron-Sulfur Cluster Biogenesis as a Critical Target in Cancer.

Authors:  Michael S Petronek; Douglas R Spitz; Bryan G Allen
Journal:  Antioxidants (Basel)       Date:  2021-09-14

3.  Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy.

Authors:  Jixue Li; Yanjie Li; Jun Wang; Trevor J Gonzalez; Aravind Asokan; Jill S Napierala; Marek Napierala
Journal:  Hum Gene Ther       Date:  2020-07-13       Impact factor: 4.793

4.  Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.

Authors:  Daniel Fil; Balu K Chacko; Robbie Conley; Xiaosen Ouyang; Jianhua Zhang; Victor M Darley-Usmar; Aamir R Zuberi; Cathleen M Lutz; Marek Napierala; Jill S Napierala
Journal:  Dis Model Mech       Date:  2020-07-27       Impact factor: 5.758

5.  Cur@SF NPs alleviate Friedreich's ataxia in a mouse model through synergistic iron chelation and antioxidation.

Authors:  Li Xu; Zichen Sun; Zhiyao Xing; Yutong Liu; Hongting Zhao; Zhongmin Tang; Yu Luo; Shuangying Hao; Kuanyu Li
Journal:  J Nanobiotechnology       Date:  2022-03-09       Impact factor: 10.435

6.  Integration of the Connectivity Map and Pathway Analysis to Predict Plant Extract's Medicinal Properties-The Study Case of Sarcopoterium spinosum L.

Authors:  Valid Gahramanov; Moria Oz; Tzemach Aouizerat; Tovit Rosenzweig; Jonathan Gorelick; Elyashiv Drori; Mali Salmon-Divon; Michael Y Sherman; Bat Chen R Lubin
Journal:  Plants (Basel)       Date:  2022-08-24

Review 7.  Therapeutic Strategies Targeting Mitochondrial Calcium Signaling: A New Hope for Neurological Diseases?

Authors:  Laura R Rodríguez; Tamara Lapeña-Luzón; Noelia Benetó; Vicent Beltran-Beltran; Federico V Pallardó; Pilar Gonzalez-Cabo; Juan Antonio Navarro
Journal:  Antioxidants (Basel)       Date:  2022-01-15

Review 8.  Predicting Mitochondrial Dynamic Behavior in Genetically Defined Neurodegenerative Diseases.

Authors:  Gerald W Dorn; Xiawei Dang
Journal:  Cells       Date:  2022-03-19       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.